Eligibility criteria
The research program follows the PRIMA-P guidelines[12], and this article is based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.[13] The inclusion criteria were as follows: (1) Population: low-risk surgical patients (Society of Thoracic Surgeons Predicted Risk of Mortality, STS PROM<4%); (2) Comparison: TAVI; (3) Control: SAVR; (4) Outcomes: Primary outcomes were all‐cause mortality and secondary outcomes were cardiovascular mortality, stroke, transient ischaemic attack (TIA), myocardial infarction (MI), acute kidney injury (stage 2 or 3), life-threatening or significant bleeding, permanent pacemaker implantation (PPI), and new atrial fibrillation (NAF); these outcome measures were assessed over a 2-year period.[14]; (5) Study design: RCTs.